Eledon Pharmaceuticals Inc (ELDN)
Equity Ratio
57.12%
Quarterly · Period ending:
ELDN Equity Ratio
Latest reported57.12%period ending
Latest reported57.12%period ending
ELDN Quarterly Equity Ratio (-171.17% → 57.12%)
Latest values, visible window
High-resolution chart · PNG
ELDN equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 57.1248% | |
| 68.4939% | |
| 47.9767% | |
| 27.23% | |
| 73.1687% | |
| 71.0318% | |
| 66.5934% | |
| 66.3821% | |
| -7.0558% | |
| -18.2237% | |
| 8.0929% | |
| 95.0723% | |
| 93.5984% | |
| 90.8707% | |
| 90.7213% | |
| 94.3223% | |
| 96.5567% | |
| 96.8645% | |
| 96.1577% | |
| 96.3752% | |
| 96.8617% | |
| 95.925% | |
| 96.6585% | |
| 11.167% | |
| 89.0963% | |
| 85.605% | |
| 86.5886% | |
| 87.8302% | |
| 88.0105% | |
| 73.8161% | |
| 85.1169% | |
| 91.956% | |
| 93.6773% | |
| 93.7531% | |
| 93.1074% | |
| 89.5738% | |
| 87.3156% | |
| 90.4495% | |
| 90.2456% | |
| 82.397% | |
| 82.9844% | |
| 89.0781% | |
| 90.8053% | |
| 92.645% | |
| 94.6688% | |
| 94.0466% | |
| 96.062% | |
| 94.9786% | |
| 84.2528% | |
| -171.1742% |